scholarly journals Using Reticulocyte Hemoglobin Equivalent (RET- He) in Diagnosis of Iron Deficiency Anemia

QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
R A R Ahmed ◽  
M H A Fayek ◽  
D A D Salem

Abstract Background Anemia is a significant worldwide health problem. Approximately one third of the world's population suffers from anemia, half of which is due to iron deficiency (ID). Evaluation of parameters relating to serum ferritin and iron is critically important in the diagnosis of iron deficiency anemia (IDA). The recent development of automated systems for hematology analysis has made it possible to measure reticulocyte hemoglobin equivalent (RET-He), which is thought to reflect iron content in reticulocytes, in the same sample used for complete blood count tests. Aim of the work We aimed to assess the role of RET- He in diagnosis of iron deficiency anemia. Subjects and Methods Blood samples were obtained from 102 subjects. Patients were classified into three groups: IDA, ID, and anemia of chronic disorder (ACD). In addition 20 age and sex matched healthy volunteers were enrolled as control. RET- He was assessed by Sysmex XN1000 hematology analyzer. Results Patients in the IDA group had significantly lower RET-He levels than those in the control group. RET-He was correlated with serum ferritin in the IDA and ID groups. The area under the curve for RET-He was 0.883. The cut-off value of RET- He for detecting IDA was ≤ 26.5 pg with 80% sensitivity and 90% specificity. Conclusion RET-He facilitates the diagnosis of IDA with high accuracy and may be a clinically useful marker for determining IDA.

Author(s):  
Rabaa Khaled Abdel Salam ◽  
Saria Naji Mohsin

This study was conducted to identify the role of some blood parameters, levels of some hormones, proteins, and cellular kinetics that have a role in iron transport and storage, in addition to their relationship with each other and with blood and sex parameters for patients with severe and moderate iron deficiency anemia, and to compare the parameters with healthy people. The study period lasted for the period from (December 2020 until March 2021) The presence of iron deficiency anemia was confirmed by examining the blood picture and the criteria of hepcidin and ferritin. The results showed a significant decrease in the in the concentration of hepcidin, ferritin and iron in patients compared to the control group.


Anemia ◽  
2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Betelihem Terefe ◽  
Asaye Birhanu ◽  
Paulos Nigussie ◽  
Aster Tsegaye

Iron deficiency anemia among pregnant women is a widespread problem in developing countries including Ethiopia, though its influence on neonatal iron status was inconsistently reported in literature. This cross-sectional study was conducted to compare hematologic profiles and iron status of newborns from mothers with different anemia status and determine correlation between maternal and neonatal hematologic profiles and iron status in Ethiopian context. We included 89 mothers and their respective newborns and performed complete blood count and assessed serum ferritin and C-reactive protein levels from blood samples collected from study participants. Maternal median hemoglobin and serum ferritin levels were 12.2 g/dL and 47.0 ng/mL, respectively. The median hemoglobin and serum ferritin levels for the newborns were 16.2 g/dL and 187.6 ng/mL, respectively. The mothers were classified into two groups based on hemoglobin and serum ferritin levels as iron deficient anemic (IDA) and nonanemic (NA) and newborns of IDA mothers had significantly lower levels of serum ferritin (P=0.017) and hemoglobin concentration (P=0.024). Besides, newborns’ ferritin and hemoglobin levels showed significant correlation with maternal hemoglobin (P=0.018;P=0.039) and ferritin (P=0.000;P=0.008) levels. We concluded that maternal IDA may have an effect on the iron stores of newborns.


2015 ◽  
Vol 39 (2) ◽  
pp. 66-71
Author(s):  
Jamal A. AL Jabbar Attawi

     This research aimed at identifying the relationship of iron-deficiency anemia caused by insufficient dietary intake and the iron-deficiency anemia caused by parasitic worms such as hookworms. Whole blood was drawn from 40 specimens; 20 males and 20 females, normal healthy controls with age ranges 8-50 year. Blood samples were collected from 80 patients with symptoms of anemia, with age range from 10-50 year. After fecal examination, they were divided into two groups: Group one, iron-deficiency anemia with non-parasitic; and group two, iron-deficiency anemia with parasitic. Blood samples were divided into two container, one for the hemoglobin, other for serum ferritin and elements of iron, zinc in tubes without anticoagulants. Results demonstrated a significant decrease in the levels of serum iron, serum ferritin, and hemoglobin in male and female patients (in group one without parasitic worms) as compared with control groups. Furthermore (in two groups with and without parasitic worms), a significant decrease in the level of serum zinc in male and female patients as compared with control group. A significant decrease in the levels of serum iron, ferritin and hemoglobin were observed in male and female patients with iron-deficiency anemia caused by parasitic hookworms compared with control group. The worm burden was classified as light, moderate and heavy as estimated by egg counts per gram of faeces, so results showed the median increase with developing of iron deficiency anemia from parasitic hookworms.


Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 4897-4897
Author(s):  
Hassan A. Al-Jafar ◽  
S Al-Fadhli ◽  
Althallab F ◽  
Mubark Al Ageeli

Abstract Hypoferritinemia Without Anemia The Possible Diagnostic Thought Hassan Al-Jafar , Saud Al-Fadli , Fatma Al-Thelab , Mubark Al-Aqeel Introduction : Iron metabolism still an active area in research work which provide more knowledge of aetiology and pathogenesis of the diseases and provide new treatment methods based on the new research results . HWA is one of the metabolic disorders where all the investigations are withen normal reference ranges . HWA patients could have long standing complain , while few HWA patients have no complains . The normal all results make HWA a hidden disease with lack in the exact underling cause . Iron deficiency anemia ( IDA ) and latent iron deficiency anemia ( LIDA ) are easy to diagnose from the clinical and the laboratory results , where IDA has anemia and LIDA has at least one paremeter in complete blood count that indicate a stage of pre-iron deficiency anemia . HWA desease has normal results except low ferritin level , ehat make pre-pre-IDA or pre-LIDA with normal transferrin saturation a stutus which was not described before . In the letreture serum ferritin found to be low in canins due to autoantibodies , also there could be another factors which not yet known that may affect iron metabolism and causing HWA . Aim: This research project is looking for interpretation for HWA to treat it by methods other than iron or iron infusion as many unpleasant and side effects accompanied both oral and intravenous iron treatment. Methodology and tools: From our hospital data and from the outpatient department 75 Patients 36 male and 39 females were reviewed to detect the variations of complete blood count parameters in comparison with iron status. Tools: Complete blood count (CBC), HPLC, serum iron, serum ferritin, transferrin. Including criteria: Adult male and female patients, normal HPLC results. Excluding criteria: Abnormal HPLC, Family history of hemoglobinopathy disorders for patients investigated prospectively, patients on iron treatment excluded from this study. Results: In IDA group usually all the parameters indicate IDA. In LIDA group at least one parameter or more indicate iron deficiency. In HWA group only, ferritin is low and transferrin saturation is normal while it is expected to be low if HWA underling aetiology is iron deficiency. Table [ 1] Conclusion: IDA and LIDA are easly diagnosed , while HWA has only low serum ferritin which is not routinely done. In HWA the results are not going with the usual parameters of iron metabolism and homeostasis, when low ferritin found with normal transferrin saturation in the same sampling days. HWA could be just an early pre- LIDA or may be a low ferritin reference range in some countries especially when the patient has no complains, or the body could have another unknow storage mechanisms other than ferritin. HWA also might be hormonal deficiency which reduce acute reactive proteins which could affect serum ferritin level or HWA could be an antibody against ferritin which has no influence on serum iron, but it renders serum ferritin lower than normal. HWA is important from many aspects , first it is a hidden disorder which need to be known by the physicians for diagnosis and treatment and it is important from academic point of view to answer to its indecisive aetiology and pathogenesis especially when it has a controversy in low ferritin and normal transferrin saturation . Adding more research tools as hepcidin test could provide more information to understand HWA disorder better. References: 1-Wei Wang , Mary Knovich , Lan G.Coffman Frank M, Torti , Suzy V. Torti , Serum ferritin :Past , Present and future Biochim Biophys acta , 2010 August ; 1800 (8) : 760-769 2-Hassan Al-Jafar, HWA: Hypoferritinemia without a hidden hematology disorder, journal of family medicine and primary care 2017, volume: 6, issue: 1 p 69-72 Disclosures No relevant conflicts of interest to declare.


Hematology ◽  
2019 ◽  
Vol 2019 (1) ◽  
pp. 323-326 ◽  
Author(s):  
Julia G. Ramos ◽  
Michelle P. Zeller

Abstract A 45-year-old woman with a history of uterine fibroids and abnormal uterine bleeding presents to the emergency department (ED) with presyncope and weakness. A gynecology consultation for definitive management was requested. The complete blood count demonstrates a hemoglobin (Hb) of 6.5 g/dL and a mean corpuscular volume (MCV) of 65 fL. What is the role of IV iron in managing iron-deficiency anemia (IDA) presenting to the ED/urgent care?


2019 ◽  
Vol 47 (3) ◽  
pp. 18-24
Author(s):  
Ratna Paul ◽  
Mst Sabrina Moonajilin ◽  
Sujit Kumar Sarker ◽  
Himel Paul ◽  
Swapna Pal ◽  
...  

Pre-eclampsia (PE) is a major cause of maternal and prenatal morbidity and mortality in developing countries. PE occurs in about 6% of the general women population. It complicates about 5-15% of pregnancies over 20 weeks and is responsible for 16% of maternal mortality. Pre-delivery serum Ferritin concentration was significantly higher in patients with eclampsia than in healthy pregnant women. The serum ferritin was the best sensitive marker of the iron status parameters reflecting the preeclampsia. The aim of the study is to explore the association between serum ferritin and Preeclampsia and to do a comparison of serum ferritin to assess risk of development preeclampsia between case and control.This is a case-control study with laboratory methods. The study was carried out in Sir Salimullah Medical College and Hospital. Serum Ferritin was tested in the department of biochemistry, Bangabandhu Sheikh Mujib Medical University (BSMMU). The study was carried out from January 2008 to December 2009 and the sample size was 80. A total of 80 pregnant women, comprising of 40 PE and 40 normotensive primi or multigravida in the third trimester were enrolled in the study. The mean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) were significantly higher in PE group on both occasions compared to normotensive women with similar chronological age gestational age. Out of the 40 cases 65% patients had severe proteinuria (+++) and 17.5% had moderate proteinuria (++) and 17.5% had mild proteinuria. The difference between case and control with respect to proteinuria was highly significant. More than two third (67.5%) of the cases did not have any iron deficiency anemia, while the rest (32.5%) had mild iron deficiency anemia. In the present study, the mean serum Ferritin level of PE group was almost 10 times higher (167.11 ± 10.43 ngm/ml) than that of controls (17.0 ± 3.03 ngm/ml) than that of control (431.0 ± 10.93 gm/dl). More than one-third of the cases showed serum ferritin >210 ngm/ml, compared to none of the control group. Serum Ferritin level is significantly higher in preeclamptic patients than the control group. Bangladesh Med J. 2018 Jan; 47 (3): 18-24


2009 ◽  
Vol 16 (02) ◽  
pp. 209-215
Author(s):  
SHAHEEN AHMED ◽  
Salman Ali ◽  
NAEEM FAREED ◽  
Mehboob Sultan ◽  
NADEEM SADIQ ◽  
...  

t r o d u c t i o n : The adherence to treatment of iron deficiency anemia often is poor in both developed and developingcountries. The current standard therapy is oral ferrous sulfate administered 3 times daily. It is possible that adherence would improve witha single-dose daily treatment regimen. O b j e c t i v e s : To compare single versus thrice daily ferrous sulfate for treatment of iron deficiencyanemia in young children. D e s i g n : Quasi experimental study Setting: Children Department Military Hospital Rawalpindi. P e r i o d : From (01Jan- to31 Mar 05 and 03 Jul to 02 Oct 05) Subjects and Methods: Total 250 patients of iron deficiency anemia (hemoglobin values: 7.0to 9.9 gm/dl and serum ferritin values: 10 ng/ml or less) were identified. Children divided into two groups and matched on the basis of age;and gender. One group (n = 125) received ferrous sulfate once daily and the control group (n = 125) received ferrous sulfate thrice dailyat a total dose of 6 mg/kg/day of elemental iron for 2 months. Hemoglobin and serum ferritin values were measured as baseline and at theend of the study. R e s u l t s : Successful treatment of anemia (target hemoglobin > 10 gm/dl) occurred in 81.42 % of the single dose and in79.83 % of thrice daily dose groups and the side effects were minimal between the two groups. Conclusion: A single versus a 3 times dailydose of ferrous sulfate resulted in a similar rate of successful treatment of iron deficiency anemia, without significant side effects.


2015 ◽  
Vol 23 (3) ◽  
pp. 275-283
Author(s):  
Ivan Tijanić ◽  
Miodrag Vučić ◽  
Lana Mačukanović Golubović

AbstractIntroduction. In recent years, determination of soluble transferrin receptor levels has been emerging as a test that can reliably indicate iron deficiency in various states, and that is non-invasive and easy to use. The aim of this study was: to determine reference values of soluble transferrin receptor concentrations in serums in our population, to examine the reliability of this method in the diagnosis of anemia due to iron deficiency and associated iron deficiency in anemia accompanying malignant hemopathies, and to identify possible limitations of the test in certain conditions.Material and Methods. The prospective research included 86 patients with anemia: 46 patients with iron deficiency anemia, and 40 patients with malignant hemopathies. The control group consisted of 40 healthy persons aging over 18.Results. Ferritin values were reduced in 76.1% of patients, while higher levels of soluble transferrin receptors appeared in 100% of patients with iron deficiency anemia. In patients with reduced serum ferritin levels, the soluble transferrin receptor/log ferritin index was statistically significantly higher than in patients in whom ferritin concentration was in the normal range (p <0.001). ROC analysis of patients with iron deficiency anemia showed that the soluble transferrin receptor/log ferritin index (AUC 0.977) and levels of soluble transferrin receptors (AUC 0.931) occupied the largest area under the curve. The best diagnostic parameter for detecting iron deficiency in patients with malignant hemopathies by ROC analysis is the soluble transferrin receptor/log ferritin index (AUC 0.770).Conclusion. Soluble transferrin receptors are useful in the diagnosis of iron deficiency anemia, especially when ferritin values are not reduced. The calculation of soluble transferrin receptor/log ferritin index is even more reliable. In patients with malignant hemopathies, the associated iron deficiency could be best indicated by soluble transferrin receptor/log ferritin index.


2022 ◽  
Vol 2022 ◽  
pp. 1-6
Author(s):  
Yan Ma ◽  
Yanbo Ma ◽  
Xiuqing Zhang ◽  
Xuejing Wang ◽  
Zhigang Sun

Objective. The purpose was to evaluate the treatment effect of iron proteinsuccinylate oral solution combined with vitamin A and D drops on children with nutritional iron deficiency anemia. Methods. 124 children treated in the outpatient department of our hospital from January 2017 to January 2020 were selected as the study subjects. They were randomly divided into control and observation two groups. The control group was treated with iron proteinsuccinylate oral solution (1.5 mL/kg) in the morning and evening, respectively. The observation group received adjuvant treatment with oral vitamin A and D drops based on the treatment of the control group. The treatment effect of proteinsuccinylate oral solution combined with vitamin A and D drops was evaluated by the serum iron (SI), serum ferritin (SF), and transferrin (TRF) levels, the values of CD3+, CD4+, and CD4+/CD8+, and other evaluation indicators. Results. After treatment, the SI and SF levels of children in both groups significantly increased ( P < 0.01 ) while the TRF level significantly decreased ( P < 0.01 ), and the SI and SF levels in the observation group increased more significantly, and the TRF level decreased more significantly compared with those in the control group ( P < 0.01 ). After treatment, the values of CD3+, CD4+, and CD4+/CD8+ of children in both groups significantly increased compared with those before treatment ( P < 0.01 ), and the values of CD3+, CD4+, and CD4+/CD8+ increased more significantly in the observation group compared with those in the control group ( P < 0.01 ). In addition, the evaluation results of treatment effect showed that the markedly effective rate in the observation group was significantly higher than that in the control group ( P < 0.01 ). Conclusion. Iron proteinsuccinylate oral solution combined with vitamin A and D drops can better improve the anemia symptoms in children, with high application value.


Sign in / Sign up

Export Citation Format

Share Document